DelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial…
<!-- Name:DistributionId Value:8828892 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->…
Browsing Tag
Conjugates
Antibody-Drug Conjugates Take Breast Cancer Field by Storm
Antibody-drug conjugates (ADCs) have taken the field of breast cancer by storm and appear poised to expand their reach into…
Treatment-Related Adverse Events of Antibody Drug Conjugates Identified
MONDAY, Nov. 21, 2022 (HealthDay News) -- Adverse effects associated with antibody-drug conjugates (ADCs) have been described in a review and meta-analysis published online Nov. 21 in…
NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development…
BELTSVILLE, Md. and DAEJEON, South Korea, Nov. 15, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC) and LegoChem Biosciences, Inc. (LCB, KOSDAQ: 141080) today announced a…
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance…
- iADCs are a next-generation modality for treating cancer and designed to boost anti-cancer activity, offering potential new options for patients who do not respond to existing cancer…